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Ingestionofarsenic, bothfromwatersuppliesandmedicinalpreparations, isknowntocauseskincancer. Theevidence
assessed hereindicatesthatarsenic canalsocauseliver, lung, kidney,andbladdercancerandthatthepopulationcancer
risksduetoarsenicinU.S. watersuppliesmaybecomparabletothosefromenvironmentaltobaccosmokeandradonin
homes. LargepopulationstudiesinanareaofTaiwanwithhigharsenic levelsinwell water(170-800jAg/L) wereusedto
establish dose-response relationships betweencancerrisksandtheconcentrationofinorganicarsenic naturally present
inwatersupplies. ItwasestimatedthatatthecurrentEPAstandardof50 ug/L,thelifetimeriskofdyingfromcancerof
the liver, lung, kidney, or bladder from drinking 1 L/day ofwatercould beas high as 13 per 1000 persons. It has been
estimatedthatmorethan350,000people intheUnitedStatesmaybesuppliedwithwatercontainingmorethan50yg/L
arsenic,andmorethan2.5millionpeoplemaybesuppliedwithwaterwithlevelsabove25 Ag/L.Foraveragearseniclevels
andwaterconsumption patternsintheUnitedStates, theriskestimatewasaround 1/1000. Althoughfurtherresearh is
needed tovalidate thesefindings, measures toreducearsenic levelsin watersuppliesshouldbeconsidered.
Introduction
Arsenic is aubiquitouselementpresentinvariouscompounds
throughout the earth's crust. It was identified in ancienttimes;
theGreekalchemistOlympiodorus reportedlyobtainedmetallic
arsenicby roasting oneofits sulfides. The useofarsenical com-
pounds increasedgreatlyduring the 18thand 19thcenturies, in-
cluding use in pigments and dyes, in preservatives of animal
hides, inglassmanufacture, agriculturlpesticides, andvarious
pharmaceutical substances.
The firstdescribed health effect, reported by Agricola inDe
Re Metallica in 1556 (1), involved arsenical cobalt, which ate
awaytheskinofthehandsofworkmen. In 1888 Hutchisonfirst
describedcarcinomaoftheskininpatientstreatedwitharsenical
mixtures forpsoriasisandotherskinconditions (2). Subsequent
investigations haveconfirmedthatingestionofinorganicarsenic
can causeskin cancerandthatinhalationofinorganicarsenic can
cause lung cancer (3).
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Both organic and inorganic arsenic are present in varying
amountsinfood. Fish, forexample, containrelativelyhighcon-
centrations of organic arsenic. However, inorganic forms of
arsenic aremuchmoretoxic thantheorganic forms. Inorganic
arsenic can be present as either arsenate [As(V)J or arsenite
[As(EI)]. AlthoughAs(III) ismoretoxic, humanmetabolismof
As(V)involvesreductiontoAs(III)beforeundergoingdetoxifica-
tionby methylation (4).
Arsenicispresentinsoilatlevelsrangingfrom0.2to40Ag/g
(rarelymorethan 10jAg/g)andinurbanairatlevelsaround0.02
.sg/m3 (3), butforthegeneral population themainexposure to
inorganic arsenic is through ingestion. Although most major
U.S. drinkingwatersuppliescontainlevelslowerthan5lAg/L, it
hasbeenestimatedthatabout350,000peoplemightdrinkwater
containingmorethan50lsg/L(5), thestandardforarsenicsetby
the U.S. Environmental Protection Agency (EPA).
Cancerriskestimatesattributedtoingestedarsenichavebeen
based on skin cancer risks alone. There is now sufficient evi-
dencetoconsiderotherinternal and more fatal cancers caused
by ingestedarsenicaswell. Thepurposeofthispaperistopre-
sentthefindingsofacancer riskassessmentofingestionofin-
organicarsenicindrinkingwaterbasedonmortalityfrominter-
nal cancers.
Cancerriskassessments suchasthis onecanbedivided into
four steps: hazard identification, dose-response analysis, ex-
posureassessment, andriskcharacterization(6). Thefirst sec-
tionofthis paperdeals with hazard identificationandpresentsSMITHETAL.
evidence indicating that, inaddition tothewell-known associa-
tion with skin cancer, ingestionofarsenic may also causeliver,
lung, bladder, andkidney cancer. Adose-responseanalysis and
risk extrapolation based on epidemiological studies ofpopula-
tions exposed to elevated levels of inorganic arsenic in their
drinking waterfollow, alongwith anassessmentofthepossibility
ofathreshold(i.e., alevelofexposurebelowwhichtherewould
be noincreaseinpopulation cancerrisks).Exposuredataarethen
describedconcerningthelevelsofarsenic inU.S. water supplies.
Finally, results ofrisk characterization are presented, and the
estimates ofcancer risksfromingestionofarsenic inU.S. drink-
ing water arecompared with thosefrom twootherhigh-risk en-
vironmental exposures: environmental tobacco smokeandradon.
Hazard Identification
The main sources ofevidence for the carcinogenicity ofin-
gested inorganic arsenic come fromhuman studies, with some
limited evidence from animal studies. Results of human in-
vestigations are described first, followed by those of animal
experiments.
Human Studies
Inhalationofinorganic arsenic hasbeen shown to causelung
cancer in studiesofsmelterworkers (3). However, evidence con-
sidered below suggests thatsystemic absorptionbytheseworkers
was insufficient to identify significantly increased risks of
cancers atothersites. Muchhighersystemic exposures have oc-
curred amongpopulations ingesting waterwithhigharsenic con-
centrations, and studies of such populations have shown in-
creased risks ofskin, liver, lung, bladder, and kidney cancers.
The plausibility of a causal association is supported by ex-
posure studies that found arsenic concentrations in skin, liver,
lung, and kidney tissues (7). Animal studies generally show
arsenic to accumulate atthese sites (8-12). Studiesofarsenic in
humans exposed to background levelshave foundvarying con-
centrations in different organs, including skin, lung, liver, and
kidney (13,14). This section presents abriefoverviewoftheskin
cancer evidence, and a more detailed analysis ofthe less pub-
licized evidence linking ingestion of inorganic arsenic with
cancer at theother more fatal sites.
Skin Cancer. Substantial evidenceledtheInternational Agen-
cy forResearch onCancer (IARC) toconcludethatingestionof
inorganic arsenic can causeskin cancer(3). Populations in coun-
tries such as Taiwan, Mexico, India, and Chile who consumed
drinking waterwithhighlevels ofarsenic hadhigh rates ofskin
cancer (15-18). InTaiwan, the prevalence ofskin cancer among
highly exposed males aged60 years andolderreached25% (15).
There arealso many corroborating reports ofskin cancer cases
resulting fromthe use oforally administered arsenical medica-
tions, particularly Fowler's solution, which waswidelyusedfor
the treatment of a variety of conditions such as asthma and
psoriasis (19-22).
LiverCancer. Angiosarcomaoftheliveris a very rare tumor,
oftenassociatedwith exposure tovinylchloride orthorotrast. It
is estimated thatonly about25 cases occur inthe United States
each year (23). In light of its rarity, even a small number of
angiosarcoma cases associated with exposure to arsenic mustbe
considered meaningful.
In 1957, Roth reportedthreecasesofliverangiosarcoma ina
seriesof27 autopsiesperformedbetween 1950and 1956among
arsenic-poisonedGermanvintners (24). AstudyinChilefound
that among agroupof 16male cancerpatients exposed to high
arseniclevelsthroughthewatersupply(200-2000Ag/L), 15had
skincarcinomas andonehadaliverangiosarcomainadditionto
chronic arsenical dermatosis (25).
Falk et al. identified 168 cases ofliver angiosarcoma in the
UnitedStatesbetween 1964and 1974(26), ofwhom7hadused
Fowler's solution for6-17years. Otherindividualcase reports
of liver angiosarcoma associated with medicinal ingestion of
arsenic havealso beenpublished (23,27,28).
Increasedmortality fromprimarylivercancerhasalsobeen
associated with arsenic ingestion in several studies. Luchtrath
compared the autopsy findings of 163 German winegrowers
diagnosed as having chronic arsenic poisoning with those ofa
controlgroupof163 menofsimilarage(29). Thewinegrowers
hadbeenheavilyexposedtoarsenicthroughdrinkingHaustrunk,
awinesubstitutemadefromanaqueousinfusionofgrapesthat
hadahigharsenic content. Livercancers were foundin fiveof
thewinegrowersbutinnoneofthecontrolgroup. Thesefindings
areconsistentwithanarseniceffectbutaredifficulttointerpret
due topossibleconfounding with alcohol intake.
Severalepidemiologicalstudiesbasedondatafromanareaof
southwestern Taiwan known to have high levels of inorganic
arsenic intheartesianwellwatersupplyhavefoundelevatedrates
oflivercancerdeaths. Themoststriking findingscome froma
studyinwhichthepopulationwasclassifiedintothreegroupsac-
cordingtothearseniclevelintheirdrinkingwater(300,300-600,
and > 600 Jg/L) (30,31). Using the number ofwells in each
categoryandtheirarsenicconcentrations, theEPAcalculatedthe
weightedaveragesforeachofthethreegroupstobe 170,470, and
800 yg/L (32). Fromthedatagivenby Chen etal. (30), an in-
creasing mortality rate ratio for liver cancer can be calculated
withincreasingarsenicconcentration: 1.2, 1.5, and2.5 formales
(p < 0.001)and 1.6,2.1, and3.6forfemales(p < 0.001) (Table 1).
Thesimilaritiesbetweenresidentsofneighboringvillageswith
respecttodiets, sociodemographic characteristics, andlifestyle
makeitunlikelythatconfoundingcouldexplaintheassociation
between waterarsenic concentrations and cancerrates.
These results are supportedbya) acase-control study in the
same area that reported a strong relationship betweenyears of
Table 1. Estimatedmortality riskratiosforliver, lung, bladder,
andkidney cancerbyarseniclevelsindrinking water in
southwestern laiwan, usingcancermortality ratesofthe
generalTaiwanese populationas reference.'
Cancer Water levels, ztg/L p-Value for
site Sex Background 170 470 800 lineartrend
Liver M 1.0 1.2 1.5 2.5 <0.001
F 1.0 1.6 2.1 3.6 <0.001
Lung M 1.0 1.8 3.3 4.5 <0.001
F 1.0 2.8 4.3 8.8 <0.001
Bladder M 1.0 5.1 12.1 28.7 <0.001
F 1.0 11.9 25.1 65.4 <0.001
Kidney M 1.0 4.9 11.9 19.6 <0.001
F 1.0 4.0 13.9 37.0 <0.001
'Based ondata from Chen etal. (30).
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consumption of well water and liver cancer (33); b) a com-
parison ofsite-specificcancermortality rates inthepopulation
of the high arsenic area with those of the general Taiwanese
population (34); c) an investigation ofcancer mortality ofpa-
tients who suffered from blackfoot disease (BFD), a vascular
disorderendemictosouthwestern Taiwanandassociatedwiththe
useofarsenic-rich artesianwellwater(35); andd)anecological
studyofcancermortalityratesandarseniclevelsinthedrinking
water of314townships inTaiwan (36).
Insummary, acausalassociationbetweeningestedarsenicand
livercanceris supportedbya series ofcase reports concerning
angiosarcomaoftheliver, an investigation ofarsenic-poisoned
winegrowers in Germany, and several studies in southwestern
Taiwan where drinking water has a naturally high arsenic
content.
LungCancer. Although inhaled arsenic is awell-known lung
carcinogen (3), little attention has been given to the evidence
relating lung cancer to arsenic ingestion. A number of case
reports link lung cancer to cutaneous signs of arsenicism
resulting from ingestion (28,37-39). Forexample, Robson and
Jelliffe described six patients with both lung tumors and skin
diseasecharacteristic ofarsenic exposure, allofwhomhadused
medicationscontaining arsenic (39). Casereportsofacommon
cancer such as lung cancerarenotconvincing bythemselves, but
the following epidemiological studiesprovide strong additional
evidence.
Lung cancer was found in 108 of the 163 arsenic-poisoned
winegrowers in Germany compared to only 14 among the con-
trols (29). Mortality data from the trade association listed 417
deaths of winegrowers, 242 of whom had lung carcinomas.
Although thewinegrowers hadheavy exposure toarsenic by in-
gestion, thepossibility thattheexposures responsible forthelung
cancers wereatleastpartly from inhalationcannotberuledout.
However, itshouldbenotedthat30ofthewinegrowers inthecase
series had skin cancer, which has been clearly linked to high
levels of ingested arsenic, but has not been found in studies of
smelter workers who have high lung cancer risks from arsenic
inhalation.
Because data on smoking were notavailable, onecould argue
thatconfounding by smoking might explain theresults. However,
ahighmortality odds ratio(40) of 14.7canbecalculated fromthe
study results, making it unlikely that smoking alone could ex-
plainthefindings. ThemainweaknessofLuchtrach's study (29)
relates tothelackofinformation onthechoiceofstudy subjects
so that selection bias cannotbe ruled out.
A study in the province of Cordoba, Argentina, examined
mortality records foralldeathsoccurringbetween 1949 and 1959
inareas withhigh arsenic indrinkingwater(average 600jsg/L)
and comparedthecause-specific mortality rates tothose ofthe
entireprovince (41). Mortality from all cancers combined was
foundtobeconsiderablyhigherthan intheprovinceas awhole
(24% of all deaths compared to 15%). Of the 556 deaths at-
tributed to cancer, 35% were found to be of the respiratory
organs. In addition, several other published reports have men-
tionedelevated ratesoflungcanceramongpatientswitharsenic-
related skindisorders in several areas ofArgentinawhere levels
of arsenic in drinking water are known to be high (42,43).
However, these findings can only be considered suggestive
evidence because they are based on observations from der-
matological practices, with little or no information on back-
groundrates, caseselection, lengthandcompletenessoffollow
up, or smoking habits.
The studies in southwestern Taiwan, described above in the
section on liver cancer, also show evidence ofelevated lung
cancermortalityrates. Whenthepopulationinthearsenic-rich
areawasdividedinthreegroupsaccordingtothearseniclevels
in drinking water, a clear dose-response relationship was ob-
served(30). AsshowninTable 1, increasingwaterarseniccon-
centrations (170, 470, and 800 tg/L) resulted in mortality rate
ratiosforlungcancerof1.8, 3.3, and4.5 formales, and2.8, 4.3
and 8.8 forfemales, respectively, usinglungcancermortality in
the general Taiwanese population forcomparison.
The results ofthe case-control study carried out inthe same
areashowedalineartrendbetweenlungcancer rates andyears
ofexposuretowellwater(p < 0.01), whichpersistedinamulti-
pleregression analysisthatcontrolledfortheeffectsofsmoking
(33). Similar findings were reported inothermortality studies
inthe samearea(34,35) andintherecentecological study car-
ried out in all ofTaiwan (36). In summary, the results ofepi-
demiological studies provide evidence that ingested inorganic
arsenic increases the riskoflung cancer.
KidneyandBladderCancer. TheTaiwaneseinvestigation of
cancer mortality described above also found a clear dose-
responserelationshipbetweenarsenicwaterlevelsandbladder
andkidney cancer(30). Inorderofincreasingwaterarseniccon-
centrations (170,470, and800 tg/L), thecorrespondingmortality
rateratiosforbladdercancerwere5.1, 12.1, and28.7 formales,
and 11.9, 25.1, and65.4forfemales, andforkidney cancer, 4.9,
11.9, and 19.6 for men and 4.0, 13.9, and 37.0 for women (see
Table 1). As with liverand lung cancer, the findings were sup-
ported by a case-control study showing a dose-response rela-
tionshipbetweenbladdercancerandyearsofartesianwellwater
consumption(p < 0.01)aftercontrolling fortheeffectsofsmok-
ing, teaconsumption, andotherdietary factors (33). Results of
otherstudies inthesameareaofTaiwanprovideadditional sup-
port for theassociation (34-36,44).
Themagnitudeoftheabovemortalityrateratiosforbladderand
kidney cancersis suchthatconfoundingby someotherriskfac-
torismostunlikely tobetheexplanation. Theevidencesuggests
a causal relationship. Similar associations have sofar notbeen
reportedelsewhereinrelationwitharsenicingestion, butnoother
populations ofcomparable sizeandexposurehavebeenstudied.
Themortality rate ratios forthesetwo cancers are sufficient-
ly high to ask why increased risks have not been consistently
detectedin studiesofsmelterworkers,Basedonurinary arsenic
levels ofworkers in a large smelter study thatreported marked
increases inlung cancerdue toarsenic inhalation(45), one can
estimate an average cumulative absorbed dose ofarsenic ofap-
proximately 3000mg. This is less thanhalfthecumulative dose
achievedby a60-year-oldworkerdrinking2 Lofwater/day atthe
lowest exposure level (170 ug/L) inthe studies inTaiwan. If, on
theotherhand, oneconsiders thegroupofworkerswithhighest
cumulative exposure, the estimate of systemic absorption
becomes comparable to thatofTaiwan. However, rates ofthese
cancers are not given. Thus the failure to detect significant in-
creases in bladder and kidney cancer among smelter workers
may beduetoacombination oftheirlower systemicexposure to
arsenic andlack ofexamination ofthe highest exposed groups.
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Nevertheless, thefindings concerning arsenicsmelters arenot
completelynegative. Arecentstudyofarsenic-poisonedworkers
and residents of a mining town in Japan found them to have
significantlyelevated ratesofcancersofthebladder, kidney, and
otherurinary organs(standardizedmortalityratio[SMR] = 766,
95% confidence interval [C.I.] 136-2795) in addition to lung
cancer (SMR = 566, 95% C.I. 266-1119) (46). Although the
urinary tract cancer SMRof766 wasbased ononly two cases,
itissignificantthatboth wereaccompaniedbyBowen'sdisease
(characterizedbyskinlesionsandassociatedwitharsenicinges-
tion). Further study of kidney and bladder cancer mortality
among smelterworkersbydurationandintensityofexposureis
warranted.
Animal Studies
Arsenic is unique in being the only established human car-
cinogenthathas notbeenestablished as acarcinogeninrodents.
TheIARCconcludedthattheresultsofanimalstudiessupply on-
ly limited evidence of carcinogenicity (47). Although most
arsenic inhalationbioassayshaveproducednegativeresults, two
groupsofinvestigatorsreportedpositivefindings inexperiments
involving intratracheal administration of arsenic (48-50).
Bioassays involvingoral exposure toarsenichaveproduced in-
conclusive results. Studies in mice given drinking water with
arsenic levels ranging from 4.0 to 100 mg/L did not show in-
creased cancer rates (51-53).
Theeffectsofarsenichavealsobeenexaminedinmousestrains
that have a high background incidence rate of spontaneous
tumors. Theresults fromtheseinvestigations havebeen incon-
sistent. In one study, sodium arsenite appeared to inhibit the
developmentandgrowthofprecancerous cellpopulations, but
once tumors developed, the growth rate was faster and the in-
cidence of multiple tumors and metastases was higher in the
arsenic-treated animals (54,55). In another study, trivalent or
pentavalentarsenicgivenindrinking waterinconjunctionwith
urethane decreased the number and size oftumors (56,57).
Another groupofinvestigatorsreportedincreasedkidneyand
liver tumors in rats treated with either trivalent orpentavalent
arsenic (58-60). Intheirlateststudy, intactmaleWistarrats were
injected with either saline or 30 mg/kg ofdiethylnitrosamine
(DEN), aknowncarcinogen. After 1 weekeach group wassub-
dividedintofourtreatmentgroups receiving 0, 160mg/LAs(Lll),
160 mg/L As(V), or 80 mg/L dimethylarsonic acid (DMA) in
drinking water. The animals were sacrificed after 10, 15, or24
months ofexposure.
Based onlimitedstatisticalanalysis, theauthorsconcludedthat
As(E) and DMA were promoters for DEN-initiated hepato-
cellularcarcinomasandthatAs(SI)andAs(V) werepromoters
for DEN-initiated renal tumors. Using data provided in the
report, wehaveconductedadditionalanalysesusingtheMantel-
Haenszel chi-square test (61). In view ofthe relatively small
number ofanimals per group (Table 2), the treatment groups
were pooled across sacrifice time points first and then across
treatments. Theresultsofthisanalysis show anincreaseintumor
incidence, bothwithandwithoutDEN, foreachformofarsenic.
The overall effect of arsenic on liver neoplastic nodules and
kidney tumors was not likely to beattributable tochance (p =
0.012 and0.013, respectively). Itisnoteworthythattheincreased
alble2. Carcinogenic effectsofarseniconintactrats.
Sacrifice timepoints, months
Treatmentgroup 10 15 24 p-Value
Liverneoplastic nodules
Salinecontrol 0/14b 0/11 0/16
Saline + As(II) 0/22 0/22 2/7 0.08c
Saline + As(V) 0/14 0/16 1/5 NA
Saline +DMA 0/10 0/21 2/6 0.06
DENcontrol 0/14 1/8 3/6 <0.1C
DEN + As(III) 0/13 3/14 5/6 0.22d
DEN + As(V) 0/9 4/9 4/7 0.2Id
DEN + DMA 1/14 2/11 7/8 O.IId
Kidney tumors
Saline control 1/14 0/11 1/16
Saline + As(III) 0/22 2/22 2/7 0.28c
Saline + As(V) 2/14 0/16 2/5 0.12c
Saline + DMA 0/10 0/221 1/6 0.28c
DEN control 0/14 0/8 2/6 0.42c
DEN + As(lII) 3/13 4/14 2/6 0.05d
DEN + As(V) 3/10 4/9 4/7 <0.01d
DEN + DMA 1/14 0/11 3/8 0.45d
Abbreviations: DMA, dimethylarsonic acid; DEN, diethylnitrosamine; NA,
notavailable (insufficient cell size toperformtest).
'Based ondata from Sirachietal. (60).
bNumberofanimals affected/number ofanimals intreatmentgroup.
CPboled across sacrifice time points and compared to saline controls using
Mantel-Haenszel chi-squaretest(p-values are forone-tailed testing).
dPooled across sacrifice time points and compared to DEN controls using
Mantel-Haenszel chi-square test(p-values are forone-tailed testing).
tumorincidenceobserved in rats occurred inliverandkidney,
twoofthetargetorgansobservedinhumans. However, the fact
thattreatedratshadsignificantlylowerweightsthancontrolrats
weakens the evidence from this study because it raises the
possibility thatincreasedcancerrateswereanindirecteffectof
exposureaffecting nutritional status.
The above data analysis provides some evidence that high
dosesofingestedarsenicmay resultincarcinogenicactivity in
rats. Although this effect was not seen in mice, the levels of
arsenicintheirdrinkingwaterwerelower, andmicemaybepro-
tectedbymethylatingarsenic morerapidlythan rats(62).
Dose-Response Analysis
SkinCancer
Skin cancer risk estimates have been derived based on the
study by Tseng etal., which involved alargepopulation inthe
endemicareaofTaiwan(15). Usingskincancerprevalencerates
frompopulationshavingdifferentarsenic levels intheirdrink-
ing water, a clear dose-response relationship was observed.
Brownetal. (63) calculatedthelifetimerisksofskincancerto
be 1.3/1000formalesand0.6/1000forfemalespermicrogramof
arsenicperday. Inthesectionthatfollows, weexaminethedose-
response relationships between arsenic levels in water and
cancersofthelung, liver,bladder, andkidneyandextrapolatethe
risktothecurrentU.S. drinkingwaterstandardof50jzg/L. We
focusonthesesitesbecausemortalityfromthesecancersismuch
higherthan from skincancer.
OtherCancers
Estimatesoftherisksofbladder, kidney, lung, andlivercancer
werebased on data from southwestern Taiwan, where a dose-
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responsegradientbetweenarsenicwaterlevelsandcancermor-
tality rates for these sites was observed (30). The statistical
testing consistedofatrendanalysisofproportionsusing linear
regression (64). Thewellwaterconcentrations weredividedinto
threecategories, withweightedaverageconcentrations estimated
to be 170, 470, and 800lAg/L (32). The mortality cancer rates
reported by Chen et al. for the three arsenic levels were used
(30), weighted by the person-years of exposure at each dose
group, asgivenbyWuetal. (31), assumingthatallcancerdeaths
forthefoursitesoccurredinpersonsmorethan20yearsofage.
Thebackgroundpopulation mortalityratesforTaiwanwereused
asintercepts. Theresultsoftheregressionanalysisareshownin
Table 3 and plotted in Figure 1, where it can be seen that the
findings are reasonably consistent with linear dose-response
relationships.
Tbble3 Regresonanalysisofarsenicindrinlin waterandcancerm lity
rates in Taiwan.
Cancer Background Slope Standard error p-Value for
site Sex mortality' estimateb ofthe slope linear trend
Liver M 28.0 0.041 0.008 <0.001
F 8.9 0.026 0.005 <0.001
Lung M 19.4 0.091 0.007 <0.001
F 9.5 0.083 0.004 <0.001
Bladder M 3.1 0.083 0.003 <0.001
F 1.4 0.091 0.002 <0.001
Kidney M 1.1 0.026 0.002 <0.001
F 0.9 0.033 0.002 <0.001
aAge-adjusted mortality per 100,000.
bThe slope represents the increase in cancermortality rate (per 100,000) per
microgram increaseofarsenic indrinking water, basedondatafromChenetal.
(30) and Wu etal. (31).
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FIGURE 1. Age-adjusted mortality rates forliver, lung, bladder, and kidney
cancer by the arsenic concentrations in drinking water and plots oflinear
regressions fordata fromstudies in Taiwan (30,31).
Is There a Threshold?
Inorganicarsenicismethylatedintolesstoxic,organicforms
at various sites in the body, in particular the liver and kidney.
Urinary excretionofinorganicarsenic isthus acombinationof
unchanged inorganic arsenicanditsmethylatedforms, DMAand
MMA (dimethylarsonic and monomethylarsinic acids). It has
been suggested that one might expect a threshold for the car-
cinogeniceffectofarsenicingestionifmethylationactivityhad
tobe saturatedbefore cancerrisks increased (32,65). Ifthe car-
cinogenic effects of arsenic are caused only by the inorganic
forms, and if ingested inorganic arsenic only reaches target
organs whenmethylation is saturated, then one might expect a
threshold forarsenic ingestionbelowwhichtherewouldbe no
riskofitcausing cancer. If, ontheotherhand, some inorganic
arsenic always passesthrough theliverunchangedand reaches
targetorgans, buttheproportionremainingininorganicform in-
creasedwithincreasingingestionofarsenic, then onewould ex-
pect a sublinear dose-response relationship between ingested
arsenic and cancer risk.
A study in mice showed that increasing the dose of either
As(mI) or As(V) two orders of magnitude resulted in a 2- to
2.5-fold increaseintheproportionexcretedintheinorganicform
(62). The data on methylation in humans, however, does not
show evidence for such a relationship. Table 4 illustrates the
distributionofurinarymetabolitesofinorganicarsenicexcreted
after different levels of exposure. Studies of individuals with
background exposurefoundthatunmethylatedinorganicarsenic
constitutedbetween 15 and 32% oftheurinary excretion ofthe
metabolites of inorganic arsenic (66-70). Occupationally ex-
posedpopulationshadvalueswithinthe same range(67,69,70),
aswell ashuman volunteerswhoingestedmeasureddosesofin-
organicarsenic(66,68,71). It canbeclearly seeninTable4that
even atlowbackground levelsofarsenic exposuremethylation
is far from complete.
Table 4. Relative distribution ofurinary metabolites ofinorganic arsenic
(unchanged In-As, MMA, DMA) after exposure to different levels of
inorganic arsenic.
Number % Excreted in urine
Source ofexposure exposed In-As MMA DMA Reference
Background 148 32 32 36 (67)
4 18 4 78 (66)
16 18 4 78 (68)
6 18 16 65 (69)
41 15 20 66 (70)
102 23 7 70 (80)
Ocupational
Smelter workers 9 19 20 61 (69)
Smelter workers 30 20 22 66 (70)
Glass workers 38 23 15 62 (67)
Gallium arsenide 27 32 9 61 (80)
workers
Experimental, Ag/kg/Lb
0.000143 6 27 21 51 (71)
7.1 3 25 21 54 (68)
9c 1 16 34 50 (66)
18c 1 7 20 73 (66)
35.5c 1 19 21 60 (66)
71.5c 1 26 32 42 (66)
Abbreviations: In-As, inorganic arsenic; MMA, monomethylarsinic acid;
DMA, dimethylarsonic acid.
'When a numberexposed is > 1, numbers represent group mean values.
bExperimental doses are via ingestion ofarsenic in water, assuming a body
weightof70kg for human studies.
CDose represents cumulative dose from 5 consecutive days.
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A recent paper(72) seems tocontradictthisevidencebyshow-
ingthatatlow exposuresmethylation is nearcomplete. However,
itshouldbenotedthatthisinferencecannotbemadebased onthe
waythedata wereanalyzed: nondetectablevalues wereaveraged
in as zero. If, infact, each inorganic arsenic species wasjust at
the detection level of0.5 ytg/L, then the total inorganic arsenic
would be roughly around 20%. Therefore, the evidence de-
scribedabovedoes notsupport athresholdforinorganicarsenic
carcinogenicity.
Exposure Assessment
Currentdietary intakeoftotalarsenicinU.S. adults, excluding
tap water, hasbeenestimated tobearound45-50pg/day (32,73).
Most ofthe arsenic derives from seafood, meat, and poultry
(80%)andgrainsandcereals(17%). Although seaoodhas ahigh
arsenic content, onlyabout5-10% isintheinorganicform(74),
and the organic forms (mainly arsenobetaine) areexcreted un-
changed (69). TheEPAestimatedthe averagetotalintakeofin-
organicarsenic fromfood, waterandotherbeverages tobeabout
17 pg/day, ofwhich 5 pg/day come from drinking water (32).
Thus, forthemajority oftheU.S. population, about30% ofin-
gestedinorganic arsenic comes fromdrinking water. However,
ifinorganic arsenic is present atthe current waterstandard (50
sg/L), drinking watercouldcontributealmost 100 pg moretothe
daily intake of inorganic arsenic. This would represent about
90% ofthedaily intake. Even at halfthat concentration, water
wouldstillbebyfarthemain sourceofinorganicarsenic (more
than 80%).
Based onseveral national water surveys, theEPAestimatedthe
national occurrenceofinorganic arsenic indrinking water(5).
Although most public water supplies contain levels below 5
pug/L, itisestimatedthatabout350,000peoplemightdrinkwater
containing morethan 50 pg/L, andabout2,500,000peopledrink
water containing more than 25 Ag/L.
Risk Characterization
Risk Estimation for the U.S. Population
Theestimatedmortality rateratios formales andfemales are
presented in Table 5. Risks for each cancer were extrapolated
linearly to anarsenicconcentration of50,g/Lfromthe regres-
sion lines shown in Figure 1. Based onthe EPXsassumption of
daily water consumption rates of 3.5 L for men and 2.0 L for
women in the hot climateofTaiwan (32), mortality rate ratios
(RR) werecalculated for adaily waterintakeof 1 L/day. The ex-
cess rate ratios, RR-1, were multiplied by the U.S. background
rate (B), which wasestimatedbydividingthenumberofdeaths
from each cancer by the total number ofdeaths, using figures
from U.S. Vital Statistics forthe year 1985 (75). Lifetime risks
ofdeath from cancersoftheliver, lung, bladder, andkidney were
thus derived for consumption of 1 L/day in the United States
(Table5). Theestimatesofdyingfromoneofthesecancersdue
to a lifetimeconsumptionofwatercontaining 50 pgofarsenic/L
at a rate of 1 L/day were 9.4/1000 for males and 17.3/1000 for
females, averaging around 13/1000. Itis importanttoemphasize
that, contrary to most risk assessments ofthe type presented
here, thecalculation ofrisks involve only a smallextrapolation
from clearly demonstrated effects at 170 ug/Landabove.
Table 5 Estimation oflifetime risks per 1000 ofdying fromcancer ofthe
kidney, bladder, lung, andliverfromconsumptionof1 L/dayofwaterwith
anarsenicconcentrationof50jAg/L.
Estimated
Cancer mortality rate Rate ratio
site/sex ratio (RR)b Bc B(RR-I)d
Liver
Male 1.07 1.02 3.67 0.1
Female 1.14 1.07 2.82 0.2
Lung
Male 1.24 1.07 76.4 5.3
Female 4.25 2.63 39.2 8.6
Bladder
Male 2.34 1.38 6.08 2.3
Female 4.25 2.63 3.14 5.1
Kidney
Male 2.18 1.34 5.02 1.7
Female 2.83 1.92 3.64 3.4
Total riskperdaily consumptionof 1 Lofwater
Male 9.4
Female 17.3
Average ofmale and female risks
13.4
aBased ondata fromsouthwestern Taiwan (30,31).
bRR = estimated mortality rateratiocalculated for waterconsumption of 1
L/day.
CB = U.S. background risk per 1000.
dB(RR.-1) = lifetime risk per 1000 from waterconsumption of 1 L/day.
Themale/femaledifferenceinriskestimationisdueinpartto
thelowerbackground cancer ratesforwomen inTaiwan, thus
making the rate ratios higher for those exposed. The EPA
assumption that men in Taiwan drink almost twice as much
water as women also decreases the estimated carcinogenic
potencyofarsenic formencomparedtowomen. Nevertheless,
themale/female riskestimatedifferences arewithin therange
ofuncertainty ofa risk assessment such as the one presented
here, andthereisnobiological reasontoconsiderfemalestobe
athigherrisk. Forthesereasonsthemaleandfemaleriskswere
averaged forapplication tothegeneral population.
Although there are no accurate data on the average arsenic
levels indrinking water fortheUnited States, estimates range
from2.0to2.5Ag/L(7,32). Usingtheestimatedaveragewater
intake in the United States of 1.6 L/day (76) and an average
arsenic waterlevelof2.5pg/L, linearextrapolationyieldedan
estimated lifetime risk ofdying from liver, lung, bladder or
kidney cancerdue to arsenic indrinking waterof1/1000.
Someanimal studies seemtoindicatethataprotein-deficient
dietincreasesarsenictoxicitybydecreasingmethylationcapaci-
ty(8). Ithasbeenhypothesizedthatpopulationsconsuming in-
adequate diets and exposed to high arsenic levels may thus be
moresusceptibletoarsenictoxicity(32). Ifnutritionallyinade-
quatedietsamongtheTaiwanesepopulationexposedtoarsenic
made them more susceptible to the carcinogenic effects of
arsenic, the extrapolated risk estimates for the average U.S.
population would be too high. However, the validity of the
Taiwanesefindingswouldremainunchanged, asthepopulations
inTaiwandrinking waterwithdifferentlevelsofarsenic were
all similarwith respect tolifestyle, education, andoccupation
(33). Variation inthedetoxificationofarsenicbymethylation,
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eitherdueto nutritional orgenetic factors, has notyetbeen in-
vestigated in humans and is an important area ofresearch that
needs tobe addressed.
Comparison with CancerRisks from Other
Environmental Exposures
TheestimatesofcancerrisksassociatedwiththecurrentU.S.
drinking water standard derived above place arsenic at the
forefront of cancer risks associated with environmental ex-
posures. There are only two known environmental exposures
with comparable risks, namely, environmental tobacco smoke
(ETS)andradoninhomes. InthecaseofETS, exposureoccurs
fromseveralsources, mainlyfromlivingwithasmokerorwork-
ingwithsmokers. TheNationalResearchCouncilestimatesthe
lifetime riskoflung cancerattributable to ETS torangefrom4
to 10/1000 (77).
Considerableattentionhasbeengiveninrecentyearstothein-
creased risk oflung cancer caused by indoor radon exposure
(78). Neroetal. (79)estimatedthattheaverageindoorconcen-
trationofradoninU.S. homesposesalifetimelungcancerrisk
ofabout 3/1000. Table 6compares the cancer risks from ETS,
radon, and arsenic indrinking water.
EvidenceThatArsenicisaBeneficialMicronutrient
Policydecisions arisingfrompotentialcancerrisksduetoin-
organicarsenicindrinkingwaterneedtoconsiderthepossibility
thatarsenic isabeneficialmicronutrient. Signsofarsenic dep-
rivation, includingdepressedgrowthandabnormalreproductive
function, havebeendescribedforthechicken, goat, pig, andrat
(32), indicating thepossibility thatarsenic, atleastininorganic
form, isanessentialnutrient. Basedontheseexperimentaldata,
variousestimatesofhumannutritional requirementshavebeen
made, rangingfrom 10to30itg/day (32). However, therelevance
oftheexperimentalanimaldatatohumansisunclear. Nohuman
arsenicdeficiencysyndromehasyetbeenreported,eventhough
many water supplies contain less than2.5 Ag/L. In contrast to
humans, rats sequesterarsenic inredblood cells (11), and itis
possiblethattheotheranimalspeciesinthedeprivationstudies
also differ from humans in arsenic storage and metabolism.
Human requirements for inorganic arsenic warrant more in-
vestigation, butthereisnoevidencetosuggestthatdeficiencyef-
fectswouldresultfromreducing levelsofarsenic inwater sup-
plies containing above-average concentrations.
Table6. Esim lifetimerisksofdyingfromcancerduetoexposuretodif-
ferentenvironmental carcinogens intheUnitedStates.
Carcinogen Risk
Environmental tobacco smoke(passive smoking)
Low exposure (not married to asmoker) 4/1000
Highexposure (married to asmoker) 10/1000
Radon inhomes
Average exposure 3/1000
High exposure (1-3% ofhomes) 20/1000
Arsenic indrinking water(1.6 L/day)
2.5jtg/L (U.S. estimated average) 1/1000
50 Ig/L(U.S. waterstandard) 21/1000
Conclusions
On the basis ofthe overall consistency ofresults from epi-
demiological studies, thereispersuasiveevidencethatinorganic
arsenic is a cause ofhuman cancer at several sites. A causal
association between ingested arsenic and skin cancer has
previously been established. The evidence presented here
stronglysupportsacausalrelationshipbetweeningestedarsenic
and both liver and lung cancer. There is also evidence from
Taiwanthatarsenic causes humankidney andbladdercancer,
although further studies are needed toconfirm these findings.
Additional research also needs to be conducted concerning
arsenic methylation andits relationship togenetic, dietary, or
otherlifestylefactors, whichmayaffectindividualdifferences
in susceptibility tothe carcinogenic effects ofarsenic.
Although the drinking water of the majority of the U.S.
population has levels ofarsenic considerably below the stan-
dard, itisestimatedthatabout350,000peopledrinkwaterwith
levelsabovethestandard, andmorethan2.5millionpeopleare
supplied with watercontaining morethan 251sg/L. The com-
parisons with ETS and radon, two recognized carcinogens of
publichealthconcern, servetopointouttheseriousenvironmen-
tal cancer risks posed by arsenic in drinking water. Although
further research is needed to validate the findings ofthis risk
assessment, measures shouldbetakentoreducearsenic levels
in water supplies.
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